Status:
RECRUITING
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
Lead Sponsor:
Chinese Academy of Sciences
Collaborating Sponsors:
Peking Union Medical College Hospital
First Affiliated Hospital of Kunming Medical University
Conditions:
Hepatocellular Carcinoma (HCC)
Microvascular Invasion (MVI)
Eligibility:
All Genders
18-18 years
Brief Summary
Hepatocellular carcinoma (HCC) is a common malignancy in China with a high mortality rate. Its early recurrence and long-term prognosis are closely associated with tumor aggressiveness. Microvascular ...
Detailed Description
Hepatocellular carcinoma (HCC) is a common malignancy in China with a high mortality rate. Early recurrence and long-term prognosis are closely linked to tumor aggressiveness. Microvascular invasion (...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Confirmed diagnosis of hepatocellular carcinoma (HCC) according to the Chinese Clinical Practice Guidelines for Primary Liver Cancer.
- Eligible for surgical intervention (hepatic resection or liver transplantation) according to the Chinese Clinical Practice Guidelines for Cancer, including stages Ia, Ib, and IIa.
- Preoperative imaging examination performed within 1 month before surgery.
- Availability of histopathological evaluation with documented microvascular invasion (MVI) status.
Exclusion
- History of prior antitumor treatment, including preoperative surgical intervention, transarterial chemoembolization (TACE), radiofrequency ablation (RFA), systemic therapy, or any other preoperative intervention.
- Presence of major vascular invasion, bile duct invasion/thrombosis, extrahepatic metastasis, or lymph node involvement.
- Diffuse hepatocellular carcinoma or tumor rupture with hemorrhage.
- Lack of key data required for primary analysis.
- Poor image quality that prevents reliable qualitative or radiomics analysis.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT07170345
Start Date
September 1 2025
End Date
September 1 2027
Last Update
September 12 2025
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Meng Chao Hepatobiliary Hospital of Fujian Medical University
Fuzhou, Fujian, China
2
Guangdong Provincial Hospital of Traditional Chinese Medicine
Guangzhou, Guangdong, China
3
Zhujiang Hospital
Guangzhou, Guangdong, China
4
Fifth Affiliated Hospital, Sun Yat-Sen University
Zhuhai, Guangdong, China